Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amphetamine is a central nervous system (CNS) stimulant and sympathomimetic agent. It is primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and, less commonly, obesity. Amphetamine increases synaptic concentrations of monoamine neurotransmitters—dopamine, norepinephrine (noradrenaline), and to a lesser extent serotonin.
Increases synaptic concentrations of monoamine neurotransmitters by reverse transport, inhibiting reuptake, weakly inhibiting MAO, and interacting with VMAT2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amphetamine.